Sign Up Today and Learn More About HeartFlow Stock
Invest in or calculate the value of your shares in HeartFlow or other pre-IPO companies through EquityZen's platform.
HeartFlow Stock
Medical Technology Company
HeartFlow is a medical technology company that provides non-invasive coronary artery disease detection services. The company's main product is HeartFlow FFRCT Analysis, which aims to help a physician evaluate whether a patient has significant coronary artery disease. HeartFlow FFRCT Analysis uses a CT scan that is ordered by a physician to generated a 3D model of the patient's coronary arteries. The analysis aims to calculate the amount of blockage in the arteries and the limited blood flow.
About HeartFlow Stock
Founded
2007
Headquarters
Redwood City, CA, US
Notable Investor
Wellington Management
Total Funding
756M
Industries
HeartFlow is a medical technology company that provides non-invasive coronary artery disease detection services. The company's main product is HeartFlow FFRÂ Analysis, which aims to help a physician evaluate whether a patient has significant coronary artery disease. HeartFlow FFRCT Analysis uses a CT scan ordered by a physician to generate a 3D model of the patient's coronary arteries. The analysis aims to calculate the amount of blockage in the arteries and the limited blood flow. The HeartFlow FFRCT Analysis is commercially available in the United States, Canada, Europe, and Japan.Â
Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 which became HeartFlow in May 2009. The company is headquartered in Redwood City, California. Notable investors include Panorama Point Partners, Capricorn Investment Group, and Baillie Gifford.
HeartFlow Press Mentions
Stay in the know about the latest news on HeartFlow
Heartflow reports 63% mortality reduction with FFRCT-guided care in PAD
bioworld • May, 13 2024
The 11 Startups Most Likely to IPO in 2024, According to Analysts
businessinsider • May, 5 2024
Cardiovascular Digital Solutions Market Expected to Reach $154.1 Billion by 2032 | CAGR of 6.2%
pharmiweb • May, 5 2024
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of ...
tradingview • Apr, 7 2024
HeartFlow earns reimbursement win for AI-based coronary solutions
massdevice • Apr, 7 2024
Investors in HeartFlow
Discover investors in HeartFlow stock and explore their portfolio companies
HeartFlow Management
Leadership team at HeartFlow
Chief Executive Officer
John Farquhar
Chief Scientific Officer
Charles Anthony Taylor
Join now and verify your accreditation status to gain access to:
- HeartFlow current valuation
- HeartFlow stock price
- Available deals in HeartFlow and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in HeartFlow stock?
Accredited investors can buy pre-IPO stock in companies like HeartFlow through EquityZen funds. These investments are made available by existing HeartFlow shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell HeartFlow stock?
Shareholders can sell their HeartFlow stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
